|
End-of-day quote
Egyptian Exchange
2026-08-30
|
5-day change | 1st Jan Change | ||
| 413.02 EGP | -7.19% |
|
-15.25% | +548.89% |
| 08-13 | GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
Stock exchange
Egyptian Exchange
BIOC 413.02 £
-7.19%
130M
£
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BIOC | 413.02EGP | -7.19% | 130M £ |
Quotes 5-day view: GlaxoSmithKline S.A.E
End-of-day quote Egyptian Exchange| 2026-08-24 | 2026-08-25 | 2026-08-26 | 2026-08-30 | 2026-08-31 | |
|---|---|---|---|---|---|
| Last | EGP 462.00 | EGP 453.00 | EGP 445.00 | EGP 413.02 | EGP 340.72 |
| Volume | 231,045 | 144,042 | 181,041 | 313,737 | 1,398,021 |
| Change | -5.20% | -1.95% | -1.77% | -7.19% | -17.51% |
| Opening | EGP 487.35 | EGP 462.00 | EGP 453.00 | EGP 445.00 | EGP 413.02 |
| High | EGP 506.00 | EGP 488.00 | EGP 470.00 | EGP 452.90 | EGP 453.00 |
| Low | EGP 460.03 | EGP 450.00 | EGP 441.00 | EGP 410.42 | EGP 330.42 |
Performance
| 1 day | -7.19% | ||
| 1 week | -15.25% | ||
| Current month | +72.26% | ||
| 1 month | +72.26% | ||
| 3 months | +472.61% | ||
| 6 months | +596.61% | ||
| Current year | +548.89% | ||
| 1 year | +651.90% | ||
| 3 years | +1,223.36% | ||
| 5 years | +1,217.45% | ||
| 10 years | +3,600.90% |
Volumes
marketsDaily volume
313,737
Avg. Volume 20 sessions
439,959
Avg. Volume 20 sessions EGP
181,711,866.18
Avg. Volume 20 sessions USD
3,579,178.63
Record volume 1
2,414,902
Record volume 2
1,829,945
Record volume 3
1,576,204
Capital turnover ratio
0.01
Float rotation
0.18
Basic data
Market Cap (EGP)
28,454,958,242
Market Cap (USD)
559,919,839
Net sales ()
3,730,502,257
Net sales (USD)
73,406,617
Free-Float
2.91 %
Free-Float capitalization (EGP)
829,405,156
Free-Float capitalization (USD)
16,320,544
Average Daily Capital Traded
0.64%
Indicators
Moving average 5 days
452.07
Moving average 20 days
450.23
Moving average 50 days
238.15
Moving average 100 days
153.43
Price spread / (MMA5)
+9.45%
Price spread / (MMA20)
+9.01%
Price spread / (MMA50)
-42.34%
Price spread / (MMA100)
-62.85%
RSI 9 days
47.02
RSI 14 days
54.43
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.19% | -15.25% | +651.90% | +1,223.36% | 560M | |
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | |
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | |
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | |
| -1.64% | -4.75% | +35.59% | +35.54% | 349B | |
| -0.39% | -2.76% | +21.39% | +38.01% | 290B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | |
| -1.05% | -2.29% | -19.91% | -54.10% | 201B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | -1.36% | -4.21% | +90.00% | +166.10% | 363.03B | |
| Weighted average by Cap. | -0.88% | -3.97% | +36.92% | +64.88% |
Historical Quotes: GlaxoSmithKline S.A.E
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 410.42 |  | 488 |
| 1 month | 241.15 | | 609 |
| Current year | 55.1 | | 609 |
| 1 year | 52.47 | | 609 |
| 3 years | 24.7 | | 609 |
| 5 years | 16.66 | | 609 |
| 10 years | 0 | | 609 |
Monthly variations
Annual variations
| 2026 | +435.30% | ||
| 2025 | +76.81% | ||
| 2024 | +1.27% | ||
| 2023 | -6.84% | ||
| 2022 | +23.58% | ||
| 2021 | +82.08% | ||
| 2020 | -14.17% | ||
| 2018 | -100.00% | ||
| 2017 | +81.72% | ||
| 2016 | -11.39% | ||
| 2015 | -10.00% | ||
| 2014 | -20.11% | ||
| 2013 | +53.22% | ||
| 2012 | +0.42% | ||
| 2011 | -39.24% | ||
| 2010 | +18.18% | ||
| 2009 | +24.72% | ||
| 2008 | -47.68% | ||
| 2007 | +0.89% | ||
| 2006 | +104.33% | ||
| 2005 | +6.65% |
- Stock Market
- Stocks
- BIOC Stock
- Quotes GlaxoSmithKline S.A.E
Select your edition
All financial news and data tailored to specific country editions
